A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter

• Published in: Emerging microbes & infections Vol. 10; no. 1; pp. 894 - 904
• Main Authors: Tsai, Wen-Yang, Ching, Lauren L., Hsieh, Szu-Chia, Melish, Marian E., Nerurkar, Vivek R., Wang, Wei-Kung
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01.01.2021; Taylor & Francis Group
• Subjects: Ammonium Chloride - pharmacology; Animals; Antibodies, Viral - blood; Antigen-Antibody Reactions; Blotting, Western; Chlorocebus aethiops; Convalescence; COVID-19 - blood; COVID-19 - immunology; Defective Viruses - genetics; Genes, Reporter; Genetic Vectors - immunology; HEK293 Cells; HIV-1 - genetics; Humans; Immunoglobulin G - immunology; Lentivirus - genetics; monomeric infrared fluorescent protein; Mutagenesis, Site-Directed; neutralization; Neutralization Tests - methods; Pandemics; Point Mutation; pseudovirus; reporter; SARS-CoV-2; SARS-CoV-2 - immunology; Spike Glycoprotein, Coronavirus - genetics; Spike Glycoprotein, Coronavirus - immunology; Vero Cells; monomeric infrared fluorescent protein; pseudovirus; SARS-CoV-2; reporter; neutralization
• ISSN: 2222-1751; 2222-1751
• DOI: 10.1080/22221751.2021.1925163

Neutralizing antibodies to SARS-CoV-2 have been shown to correlate with protection in animals and humans, disease severity, survival, and vaccine efficacy. With the ongoing large-scale vaccination in different countries and continuous surge of new variants of global concerns, a convenient, cost-effective and high-throughput neutralization test is urgently needed. Conventional SARS-CoV-2 neutralization test is tedious, time-consuming and requires a biosafety level 3 laboratory. Despite recent reports of neutralizations using different pseudoviruses with a luciferase or green fluorescent protein reporter, the laborious steps, inter-assay variability or high background limit their high-throughput potential. In this study we generated lentivirus-based pseudoviruses containing a monomeric infrared fluorescent protein reporter to develop neutralization assays. Similar tropism, infection kinetics and mechanism of entry through receptor-mediated endocytosis were found in the three pseudoviruses generated. Compared with pseudovirus D614, pseudovirus with D614G mutation had decreased shedding and higher density of S1 protein present on particles. The 50% neutralization titers to pseudoviruses D614 or D614G correlated with the plaque reduction neutralization titers to live SARS-CoV-2. The turn-around time of 48-72 h, minimal autofluorescence, one-step image quantification, expandable to 384-well, sequential readouts and dual quantifications by flow cytometry support its high-throughput and versatile applications at a non-reference and biosafety level 2 laboratory, in particular for assessing the neutralization sensitivity of new variants by sera from natural infection or different vaccinations during our fight against the pandemic.